-
公开(公告)号:US20230288338A1
公开(公告)日:2023-09-14
申请号:US17911452
申请日:2021-03-17
Inventor: Ryo NISHIHARA , Ryoji KURITA
IPC: G01N21/64 , C07D487/04 , G01N33/68
CPC classification number: G01N21/6428 , C07D487/04 , G01N33/6803 , G01N2021/6439
Abstract: The present invention provides a novel compound or the like useful as a luminescent molecule serving as a substrate for a human-derived protein. The compound according to the present invention is a compound represented by the following formula [I], or a salt thereof, or a hydrate or solvate thereof.
-
公开(公告)号:US20180273539A1
公开(公告)日:2018-09-27
申请号:US15926204
申请日:2018-03-20
Applicant: KEIO UNIVERSITY , NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY , The University of Tokyo
Inventor: Koji SUZUKI , Daniel CITTERIO , Ryo NISHIHARA , Sung-Bae KIM , Moritoshi SATO , Takahiro NAKAJIMA
IPC: C07D487/04 , C07D405/06 , C09K11/06 , C12Q1/66
CPC classification number: C07D487/04 , C07D405/06 , C09K11/06 , C09K2211/1022 , C12Q1/66
Abstract: There is provided a series of coelenterazine (CTZ) derivatives as a substrate with high luminescence intensity, which is optimal for maximum luminescence wavelengths at both 400 nm (blue-shifted RLuc luminescence system) and 500 nm (ALuc luminescence system) for bioassays which is more sensitive than known techniques. The novel CTZ derivatives are compounds in which a specific position(s) of the CTZ is/are substituted with a specific substituent(s) as shown, for example, by the Formula [I], and has a higher luminescence intensity than known CTZ derivatives in blue-shifted RLuc luminescence system or ALuc luminescence system.
-